BiPar Sciences Obtains $20,000,000 Series B Financing

  • Feed Type
  • Date
    1/13/2009
  • Company Name
    BiPar Sciences
  • Mailing Address
    1000 Marina Blvd Brisbane, CA 94005
  • Company Description
    BiPar Sciences Inc. is a clinical-stage biopharmaceutical company developing and commercializing a novel class of tumor-selective drugs designed to meet the significant unmet needs of cancer patients.
  • Website
    http://www.biparsciences.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $20,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy